The Current Landscape of Glioblastoma Biomarkers in Body Fluids
Open Access
Abstract
Glioblastoma (GBM) is a highly aggressive and lethal primary brain cancer that necessitates early detection and accurate diagnosis for effective treatment and improved patient outcomes. Traditional diagnostic methods, such as imaging techniques and tissue biopsies, have limitations in providing real-time information and distinguishing treatment-related changes from tumor progression. Liquid biopsies, used to analyze biomarkers in body fluids, offer a non-invasive and dynamic approach to detecting and monitoring GBM. This article provides an overview of GBM biomarkers in body fluids, including circulating tumor cells (CTCs), cell-free DNA (cfDNA), cell-free RNA (cfRNA), microRNA (miRNA), and extracellular vesicles. It explores the clinical utility of these biomarkers for GBM detection, monitoring, and prognosis. Challenges and limitations in implementing liquid biopsy strategies in clinical practice are also discussed. The article highlights the potential of liquid biopsies as valuable tools for personalized GBM management but underscores the need for standardized protocols and further research to optimize their clinical utility.Keywords
This publication has 117 references indexed in Scilit:
- Epigenetics and cancer metabolismCancer Letters, 2015
- miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patientsInternational Journal of Oncology, 2014
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2014
- Detection of Brain Tumor Cells in the Peripheral Blood by a Telomerase Promoter-Based AssayCancer Research, 2014
- Tumor Heterogeneity and Personalized Cancer Medicine: Are we Being Outnumbered?Future Oncology, 2014
- miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker DevelopmentPLOS ONE, 2013
- Plasma MicroRNA-21 Concentration May Be a Useful Biomarker in Glioblastoma PatientsCancer Investigation, 2012
- MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activityNeuro-Oncology, 2012
- A specific miRNA signature in the peripheral blood of glioblastoma patientsJournal of Neurochemistry, 2011
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature Cell Biology, 2008